Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06021613 · ClinicalTrials.gov registry record · NA
The MARY-JANE Cannabis and Heart Rhythm Trial
A NA study of Premature Atrial Contractions and Premature Ventricular Contractions, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT06021613: Active NA study of Premature Atrial Contractions and Premature Ventricular Contractions, sponsored by University of California, San Francisco.
NCT06021613 is a NA study of Premature Atrial Contractions and Premature Ventricular Contractions that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06021613, a NA study of Premature Atrial Contractions and Premature Ventricular Contractions, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
Despite recreational cannabis now being legal in 23 states, where more than 100 million Americans reside, studies on the actual health effects are limited. This study is a randomized trial, where each participant will be instructed to consume or avoid cannabis on randomly assigned days during a 14-day monitoring period. The goal of this study is to answer the question: "Does cannabis use increase the frequency of 'early' and abnormal heart beats?" During the 14-day period, participants will wear an external heart monitor, a glucose monitor, and a fitness tracker to track heart rhythm, glucose levels, step counts, and sleep health. Participants will use a mobile app or a text messaging service for daily instructions/reminders on cannabis use, and short surveys. The investigators ask that participants smoke or vape cannabis at least once on days they are instructed to consume cannabis. Compelling evidence of heart and other health effects would be important to the clinical care of our patients.
Primary Outcome
Participants will be wearing a continuously recording ECG monitor for two weeks. The primary outcome will be change in premature atrial contraction (PAC) and PVC frequency due to cannabis consumption or avoidance during the monitoring period.
Conditions Studied
Interventions
- BEHAVIORAL Randomized instructions
Study Locations (2)
California
- UCSF Medical Center at Parnassus - San Francisco
- UCSF Medical Center at Mission Bay - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2026-11 |
| Phase | NA |
What the registry record for NCT06021613 still lists
NCT06021613 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Premature Atrial Contractions appearing as the primary indexed condition, and to 1 intervention - of which Randomized instructions is the first listed.
NCT06021613 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06021613 about?
NCT06021613 is a clinical study titled "The MARY-JANE Cannabis and Heart Rhythm Trial". Despite recreational cannabis now being legal in 23 states, where more than 100 million Americans reside, studies on the actual health effects are limited. This study is a randomized trial, where each participant will be instructed to consume or avoid cannabis on randomly assigned days during a 14-d...
What is the current status of trial NCT06021613?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-01-18. Estimated completion is 2026-11.
What conditions does trial NCT06021613 study?
This clinical trial studies the following conditions: Premature Atrial Contractions, Premature Ventricular Contractions.
What interventions are being tested in trial NCT06021613?
The interventions under investigation include: Randomized instructions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06021613?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06021613 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06021613's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI